Telegram
Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиGenocea Biosciences Мультипликаторы 2011-2024 | GNCA
Мультипликаторы по годам Genocea Biosciences
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-2.2 | -2.8 | -1.1 | 136.8 | -0.5 | -2.5 | -1.8 | -3.8 | - | - | - |
P/S |
44.3 | 91.6 | - | - | - | 521.4 | 113.5 | 435.1 | - | - | - |
EPS |
-0.5 | -1.0 | -1.9 | -0.3 | -2.0 | -1.8 | -1.7 | -2.3 | -75.5 | -51.4 | - |
EV (Enterprise Value) |
64.4 млн | 134 млн | 30.2 млн | 45.3 млн | 37.4 млн | 119 млн | 81.3 млн | 132 млн | 2.12 млн | -4.29 млн | 2.65 млн |
EBITDA per Share |
-0.74 | -1.03 | -1.84 | -3.72 | -14.3 | -13.1 | -13.2 | -16.7 | - | - | - |
EV/EBITDA |
-1.2 | -2.3 | -0.4 | -0.9 | -0.6 | -2.4 | -1.9 | -3.8 | - | - | - |
PEG |
0.06 | 0.09 | 0.04 | 0.02 | -0.04 | -4.3 | 0.08 | -0.05 | - | - | - |
P/B |
2.7 | 13.9 | 1.7 | 6.5 | -4.3 | 2.7 | 0.8 | 4.1 | - | - | - |
P/CF |
-1.6 | -3.0 | -1.1 | -1.2 | -0.5 | -2.8 | -1.8 | -4.6 | - | - | - |
ROE % |
-122.61 | -486.68 | -155.54 | 4.77 | 937.36 | -108.85 | -47.38 | -108.58 | - | - | - |
ROA % |
-59.31 | -44.38 | -74.03 | 1.12 | -324.28 | -70.92 | -37.88 | -69.99 | - | - | - |
ROCE % |
-192.40 | -63.93 | -84.15 | -193.88 | -3079.99 | -81.05 | -38.96 | -74.38 | - | - | - |
Current Ratio |
1.9 | 1.1 | 1.9 | 1.3 | 0.8 | 6.2 | 16.0 | 8.2 | - | - | - |
DSO |
- | - | - | - | - | - | - | 24.9 | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально Genocea Biosciences
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
- | - | - | -0.22 | - | -0.05 | -0.06 | -0.18 | - | -0.08 | -0.39 | -0.46 | -0.34 | -0.28 | -0.42 | -1.22 | 0.03 | -0.72 | -0.42 | -0.22 | -0.37 | -0.59 | -0.54 | -0.48 | -0.56 | -0.45 | -0.39 | -0.35 | 28118000 | -0.37 | -0.43 | -640 | -0.66 | -0.53 | -0.41 | -0.76 | -22.5 | -17.72 | -18.1 | -17.09 | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | - | -0.22 | - | -0.17 | -0.21 | -0.18 | - | -0.18 | -0.36 | -0.47 | - | -0.33 | -0.62 | -0.72 | - | -0.89 | -0.86 | -0.14 | - | -0.53 | -0.49 | -0.45 | - | -0.39 | -0.35 | -0.32 | - | -0.33 | -0.4 | -0.62 | - | -0.5 | -0.39 | -0.64 | - | -14.3 | -15.5 | -15 | - | - | - | - | - | - | - | - |
ROE % |
-258.02 | -267.60 | -148.16 | -254.47 | -795.97 | -818.51 | -831.48 | -851.21 | -291.68 | -329.04 | -330.51 | -230.40 | -149.47 | -107.34 | -190.12 | -224.69 | -379.15 | -206.54 | 179.06 | 493.70 | 937.36 | 724.76 | 417.92 | 139.58 | -108.85 | -85.15 | -68.02 | -55.32 | -47.38 | -71.72 | -89.03 | -99.51 | -108.58 | -64.82 | -30.57 | -2.40 | 25.96 | 18.05 | 12.01 | 5.82 | - | - | - | - | - | - | - | - |
ROA % |
-82.39 | -87.97 | -52.35 | -57.92 | -25.43 | -29.72 | -28.43 | -34.35 | -44.22 | -62.01 | -72.03 | -72.89 | -74.03 | -55.13 | -65.98 | -67.90 | -89.38 | -151.87 | -223.15 | -296.81 | -324.28 | -285.85 | -207.66 | -135.51 | -70.92 | -57.18 | -47.63 | -41.06 | -37.88 | -51.83 | -61.34 | -66.34 | -70.10 | -87.22 | -99.70 | -116.95 | -132.01 | -91.75 | -61.04 | -29.59 | - | - | - | - | - | - | - | - |
ROCE % |
-254.71 | -285.68 | -189.30 | -548.02 | -1094.68 | -1147.83 | -1170.01 | -935.55 | -326.32 | -356.87 | -334.27 | -250.20 | -108.59 | -251.19 | -363.25 | -456.49 | -417.61 | -144.95 | 270.31 | 651.66 | 741.65 | 714.36 | 414.40 | 143.00 | -71.50 | -82.09 | -65.38 | -53.06 | -34.90 | -62.46 | -79.43 | -89.50 | -68.42 | -62.83 | -29.69 | -2.51 | 17.17 | 17.17 | 11.58 | 5.65 | - | - | - | - | - | - | - | - |
Current Ratio |
- | - | - | 1.5 | 1.9 | 2.4 | 1.1 | 1.0 | 1.1 | 1.2 | 1.1 | 1.4 | 1.9 | 1.9 | 1.9 | 1.9 | 1.3 | 1.3 | 1.3 | 1.3 | 0.7 | 0.7 | 0.7 | 0.7 | 2.9 | 2.9 | 2.9 | 2.9 | 5.0 | 5.0 | 5.0 | 5.0 | 2.8 | 2.8 | 2.8 | 2.8 | 1.1 | 1.1 | 1.1 | 1.1 | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD